Riyadh, King Fahad Medical City has become the first institution in Saudi Arabia to earn accreditation in interventional oncology from the International Accreditation System for Interventional Oncology Services (IASIOS). The accreditation is proof of the fact that the hospital's interventional oncology services have met the highest international standards of excellence, including compliance with the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) Standards of Quality Assurance in Interventional Oncology. This achievement is also testament to the hard work and dedication of the medical team at King Fahad Medical City, which is part of the Riyadh Second Health Cluster. "Congratulations to the team for their hard work throughout the application process, proving their adherence to the CIRSE Standards of Quality Assurance in Interventional Oncology," stated the official IASIOS website. This four-year accreditation cements King Fahad Medical City's position as a leading national provide r of cancer treatment, research, and related services. This recognition underscores the unwavering commitment of the medical city to deliver world-class healthcare, according to the highest global standards. Source: Saudi Press Agency